New Poll Finds Millions Of Smokers Nationwide Resolving To Quit In The New Year
Among smokers who did speak with their HCPs about quitting in the last 12 months, nearly four in ten believe that the discussion motivated them to quit (38 percent) or helped them to take the next step towards quitting (35 percent). "Overcoming the initial barrier of speaking with a primary care physician, pharmacist or dentist is critical. Once the conversation does get going, the outcomes can be extremely helpful to bolstering the quit attempts and ensuring the results are long-lasting," Healton said.
Among the 45 percent of smokers surveyed who did speak with their HCP about quitting smoking, many reported that during conversations in the last 12 months, their HCP commonly recommended nicotine replacement products (49 percent) and prescription medications (49 percent) to help them quit. However, most have yet to adopt recommended treatments. Nationally representative studies have shown that people trying to quit smoking improve their likelihood of success if they utilize FDA-approved medications.
Nearly two-thirds (64 percent) of those who tried to quit in the past year prepared for only a week ahead of time, at most. Giving up smoking is very difficult; having a plan and a support network including a healthcare provider and tools lined up in advance can help considerably. The poll showed that 69 percent of smokers are thinking about quitting within the next year, with a majority, 79 percent, of this group either in the process of quitting already or planning to do so within the next six months.
Smokers looking to quit should visit www.BecomeAnEX.org. The site offers a free personalized online plan that can help any smoker start on the path to quit by offering proven-effective smoking cessation tools and information. The program was created by Legacy, a national public health foundation, with input from current and former smokers along with tobacco treatment experts at the world-renowned Mayo Clinic.* The survey was sponsored by Legacy and partly funded by Pfizer; Kelton, a leading global insights firm facilitated the survey in November and December 2012. About the Survey The survey was conducted between November 26th and December 5th, 2012 among 1,552 Americans 18 and over who have smoked at least 100 cigarettes in their lifetimes and still smoke at least occasionally, using an email invitation and an online survey. Results of any sample are subject to sampling variation. The magnitude of the variation is measurable and is affected by the number of interviews and the level of the percentages expressing the results. In this particular study, the chances are 95 in 100 that a survey result does not vary, plus or minus, by more than 2.5 percentage points from the result that would be obtained if interviews had been conducted with all persons in the universe represented by the sample. The margin of error for any subgroups will be slightly higher. About Legacy®: Legacy helps people live longer, healthier lives by building a world where young people reject tobacco and anyone can quit. Legacy's proven-effective and nationally recognized public education programs include truth ® , the national youth smoking prevention campaign that has been cited as contributing to significant declines in youth smoking; EX ® , an innovative public health program designed to speak to smokers in their own language and change the way they approach quitting; and research initiatives exploring the causes, consequences and approaches to reducing tobacco use. Located in Washington, D.C., the foundation was created as a result of the November 1998 Master Settlement Agreement (MSA) reached between attorneys general from 46 states, five U.S. territories and the tobacco industry. To learn more about Legacy's life-saving programs, visit www.LegacyForHealth.org . Follow us on Twitter @legacyforhealth and Facebook www.Facebook.com/Legacy . SOURCE Legacy
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts